Related Experiment Video
Updated: Apr 28, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Preeclampsia: integrated network model of platelet biomarkers interaction as a tool to evaluate the
Letícia Gonçalves Freitas1, Renato Sathler-Avelar2, Danielle Marquete Vitelli-Avelar2
1Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia-Universidade Federal de Minas Gerais, Brazil.
Insights
Preeclampsia (PE) is not linked to higher platelet activation markers. Researchers found no single biomarker for diagnosing or predicting PE, despite observed correlations in severe cases.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Immunology
Background:
- Preeclampsia (PE) is linked to platelet activation, potentially driving coagulation and inflammation.
- Investigating platelet activation, platelet-leukocyte aggregates (PLA), and monocyte tissue factor (TF) as diagnostic biomarkers for PE.
Purpose of the Study:
- To determine if platelet activation markers, PLA, and monocyte TF expression can serve as biomarkers for preeclampsia diagnosis and prognosis.
Main Methods:
- Flow cytometry was used to analyze platelet markers in 97 women (severe PE, mild PE, normotensive pregnant, non-pregnant).
- Evaluated platelet counts, CD41a and CD61 expression, PLA frequency, and monocyte TF expression.
Main Results:
- Platelet counts and CD41a expression were lower in non-pregnant and severe PE groups compared to non-pregnant controls.
- No significant differences in PLA and monocyte TF expression were found among groups.
- Correlations between platelet activation markers were noted, particularly in severe PE, suggesting hemostatic/immunological interplay.
Conclusions:
- Preeclampsia is not associated with elevated platelet activation markers.
- No single laboratorial biomarker was identified for PE diagnosis or prognosis.
- The role of platelet activation in PE pathophysiology requires further investigation.
Background:
Preeclampsia (PE) is associated with platelet activation, which may be involved in its pathogenesis promoting coagulation and mediating inflammation. We investigated whether the platelet activation status together with the frequency of platelet-leukocyte aggregates/PLA and monocyte tissue factor/TF expression could be used as laboratorial biomarkers for PE diagnosis and prognosis.
Methods:
Ninety-seven women were evaluated including severe PE/sPE (N=15), mild PE/mPE (N=20), normotensive pregnant/NP (N=31) and non-pregnant women/nonP (N=31). Platelet markers were analyzed by flow cytometry.
Results:
Platelet counts and CD41a expression by platelets were lower in NP and sPE vs nonP. The expression of CD61 was lower during pregnancy. Altered balance of platelet marker expression was also observed in NP and sPE vs nonP. No significant differences in the PLA and TF expression by monocytes were observed among the groups. There are several correlations between platelet activation markers, especially in sPE, which suggest a relevant role of the hemostatic/immunological cross-talk in this disease.
Conclusions:
PE is not associated with increased platelet activation markers. It cannot rule out a role of platelet activation in the PE pathophysiology. Despite those correlations, we did not find a putative laboratorial biomarker that could be useful by itself for PE diagnosis and prognosis.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Intracellular Signaling Affects Focal Adhesions
Some...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...

